Nanomedicines offer nanoscale drug delivery system. They offer ways of capable drug transportation, and address the issues of lack of targeting and permeability of traditional drugs. The physical and chemical properties in the field of nanomedicine applications in vivo have not been sufficiently distributed. Besides, the metabolic of nanomedicines is not clear enough. Those factors which mentioned above defines that many nanomedicines have not yet realized clinical application due to their safety problems and in vivo efficacy. For example, they may cause immune response and cytotoxicity, along with the ability to clear organs in vivo, the penetration ability of them and the lack of targeting ability may also cause less effectiveness of drugs in vivo. In this review, the new progresses of different kinds of nanomedicines in antitumor, antibacterial, ocular diseases and arteriosclerosis in recent years were summarized. Their shortcomings were pointed out, and the new approaches to improve the biosafety and efficacy were summarized. 

Submit Abstract

Related TagsNanomedicine Conferences | Nanomedicine Conferences 2022 | Nanomedicine Conference 2022 | Nanomedicine Congress | Nanomedicine Congress 2022 | Nanomedicine Conferences 2022 | Nanomedicine Conference | Nanomedicine Hybrid Event | Nanomedicine Hybrid Event 2022 

Related AssociationsAustrian Society of Toxicology | Bangladesh Society of Toxicology | Brazilian Society of Toxicology | Bulgarian Toxicological Society | Cameroon Society for Toxicological Sciences | Columbia Society of Toxicology